Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationBone MarrowAnemia, AplasticBone Marrow CellsBusulfanLeukemiaHistocompatibility TestingTransplantation, AutologousGraft vs Host ReactionHematopoietic Stem Cell TransplantationCyclophosphamideTransplantation ConditioningLiver TransplantationMethotrexateTransplantation ChimeraGraft SurvivalRecurrenceTissue DonorsHistocompatibilityCytomegalovirus InfectionsKidney TransplantationHematopoietic Stem CellsTransplantation, IsogeneicBone and BonesGraft RejectionBone Marrow PurgingHematologic NeoplasmsStem Cell TransplantationImmunosuppressive AgentsHematopoiesisImmunosuppressionCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesLymphocyte DepletionTreatment OutcomeLeukemia, Myeloid, AcuteBone Marrow DiseasesTime FactorsMice, Inbred C57BLHeart TransplantationTransplantation ImmunologyRadiation ChimeraAcute DiseaseRemission InductionT-LymphocytesStem CellsSurvival AnalysisHLA AntigensNuclear FamilyPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineHepatic Veno-Occlusive DiseaseLung TransplantationRetrospective StudiesBone Marrow ExaminationLeukemia, MyeloidLeukocyte TransfusionLymphoma, Non-HodgkinOrgan TransplantationMyelodysplastic SyndromesChimeraBone Marrow NeoplasmsSevere Combined ImmunodeficiencyColony-Forming Units AssayGraft vs Tumor EffectHematologic DiseasesGraft vs Leukemia EffectActuarial AnalysisInfectionCyclosporinsSurvival RateAntineoplastic Combined Chemotherapy ProtocolsLymphocyte TransfusionCell TransplantationCell DifferentiationSpleenIslets of Langerhans TransplantationCarmustineMice, Inbred BALB CCord Blood Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationCytarabineGranulocyte Colony-Stimulating FactorPancytopeniaLeukocyte CountPancreas TransplantationMelphalanBone RemodelingFlow CytometrySkin TransplantationCystitisTransplantationCells, CulturedLife TablesMultiple MyelomaDisease-Free Survival